Emergent BioSolutions Inc. Annual Share-based Payment Arrangement, Expense in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Emergent BioSolutions Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2010 to 2023.
  • Emergent BioSolutions Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $5.5M, a 33.7% decline year-over-year.
  • Emergent BioSolutions Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $19.4M, a 48.9% decline year-over-year.
  • Emergent BioSolutions Inc. annual Share-based Payment Arrangement, Expense for 2023 was $23.1M, a 48.8% decline from 2022.
  • Emergent BioSolutions Inc. annual Share-based Payment Arrangement, Expense for 2022 was $45.1M, a 6.37% increase from 2021.
  • Emergent BioSolutions Inc. annual Share-based Payment Arrangement, Expense for 2021 was $42.4M, a 18.1% decline from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $23.1M -$22M -48.8% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-08
2022 $45.1M +$2.7M +6.37% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-08
2021 $42.4M -$9.4M -18.1% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-08
2020 $51.8M +$25.1M +94% Jan 1, 2020 Dec 31, 2020 10-K/A 2023-12-11
2019 $26.7M +$3.5M +15.1% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-25
2018 $23.2M +$8M +52.6% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-19
2017 $15.2M -$3.3M -17.8% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-25
2016 $18.5M +$2.65M +16.7% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-22
2015 $15.8M +$3.02M +23.5% Jan 1, 2015 Dec 31, 2015 10-K 2018-02-23
2014 $12.8M +$1.59M +14.2% Jan 1, 2014 Dec 31, 2014 10-K 2017-02-28
2013 $11.2M +$123K +1.11% Jan 1, 2013 Dec 31, 2013 10-K 2016-02-29
2012 $11.1M +$376K +3.5% Jan 1, 2012 Dec 31, 2012 10-K/A 2015-03-09
2011 $10.7M +$3.68M +52% Jan 1, 2011 Dec 31, 2011 10-K 2014-03-10
2010 $7.06M Jan 1, 2010 Dec 31, 2010 10-K 2013-03-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.